---
title: "Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap"
description: "Despite mixed results from Trauma players, the segment experienced healthy growth as mergers & acquisitions were plentiful & regulatory clearances show promise of future new product introductions ... #orthopedic #trauma"
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap](https://blog.smarttrak.com/healthy-growth-w/-mixed-results-q122-trauma-market-recap)

 Written by [Natasha Weeks](https://blog.smarttrak.com/author/natasha-weeks) | 7/28/22 1:30 PM

*<https://app.smarttrak.com/analysis/qs/c0d5b5f9deb0aeb7ac10027421db64a9>Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.*

Despite an overall healthy first quarter for the Trauma Market, players in the space reported mixed results. Top players [DePuy Synthes*](https://app.smarttrak.com/companies/qs/28649) and [Stryker](https://app.smarttrak.com/companies/qs/9) experienced healthy returns while [Smith & Nephew*](https://app.smarttrak.com/companies/qs/37) and [Zimmer Biomet*](https://app.smarttrak.com/companies/qs/40) noted headwinds based on geography and product category. Globus, no longer a real newcomer to the trauma segment, but a company SmartTRAK continues to monitor, experienced its strongest quarter to date and the Company continues to expand its salesforce.

Among the many topics covered in detail in our comprehensive [Q122 Trauma Market Recap](https://app.smarttrak.com/analysis/qs/c0d5b5f9deb0aeb7ac10027421db64a9)* are:

- Complete Q122 Trauma Market Overview
- SmartTRAK's Expert Analysis and Insights
- All Market News including Revenues, Data, Charts and Shares
- Mixed Results for Trauma Players
- Mergers & Acquisitions Impact Trauma & Extremities
- Regulatory Highlights Indicate New Future Product Offerings

Deals in the Extremities space outpaced 2021 with three acquisitions completed in the first quarter of 2022 and a strategic partnership announced. In January, Paragon 28 acquired ...

[Read the entire Q122 OrthoBio Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares](https://blog.smarttrak.com/ending-on-a-bright-note-q122-orthobio-market-recap)*

*The entire unedited article and these links can only be viewed by [SmartTRAK](https://www.smarttrak.com/) subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please[ click](https://www.smarttrak.com/contact-us) the button below.

[SmartTRAK ](https://www.smarttrak.com/)is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click [here](https://blog.smarttrak.com/cs/c/?cta_guid=1c24ae7a-5393-4c47-a76d-d18136ff727d&placement_guid=2f7e3c58-0123-4bec-98a4-b2b117882b09&portal_id=3044256&canon=https%3A%2F%2Fblog.smarttrak.com%2Finternational-medtech-news-roundup-updates-from-around-the-globe&redirect_url=APefjpGHZoXayOkESMYPXQOOsNHBm-i571cr4faLAvrDXprThXmHk5M9wYko0AtjJEEMt_Q3MRyoAf8xHg9ENWuq5GFHyQMJzAQmw11VAbWdd7H9iHt1nE97j2Zsoe7hSY82UKR-rYAr4dplUEP1rcM3FGyWY7yRjCqE2qXdnv6capCyZCdh1L_9H0tJtOr9tsoBEnCYdOKD6BuNqu2lHSMyytUN8WixnfKAFmD3IoC_xw17EeTBUCoCgF01BQOWbGdQ3u63Hq4F_Ybq86EzWbmEFq2gHOB9Rw&click=32771a22-e7df-4f95-baef-1e3c0f41cdd0&hsutk=e6a6e791d25da80e0f0e686f28213679&signature=AAH58kFnC16-53FyXBNco_4FUi0_OYO6Bw&utm_referrer=https%3A%2F%2Fblog.smarttrak.com%2F&pageId=31386535169&__hstc=143483370.e6a6e791d25da80e0f0e686f28213679.1594601834574.1594680236191.1594683837460.8&__hssc=143483370.3.1594683837460&__hsfp=2682177187&contentType=blog-post).

[View full post](https://blog.smarttrak.com/healthy-growth-w/-mixed-results-q122-trauma-market-recap)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Natasha Weeks"
  },
  "dateModified" : "2022-07-28T13:30:00.371Z",
  "datePublished" : "2022-07-28T13:30:00Z",
  "headline" : "Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap",
  "image" : {
    "@type" : "ImageObject",
    "height" : 512,
    "url" : "https://3044256.fs1.hubspotusercontent-na1.net/hubfs/3044256/Q222%20Trauma%20Recap%20Header%20V3.png",
    "width" : 1024
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/healthy-growth-w/-mixed-results-q122-trauma-market-recap",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```